Outcomes of VDPACE with Immunomodulator Agent as a Salvage Therapy for Relapsed/Refractory Multiple Myeloma

被引：0
|
作者：
Abdallah, Al-Ola [1 ]
Shune, Leyla [1 ]
Hochard, Erica [1 ]
Dunavin, Neil [1 ]
Mahmoudjafar, Zahra [1 ]
Ganguly, Siddhartha [1 ]
机构：
[1] Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
Multiple Myeloma; Extramedullary disease; Plasmacytoma;
D O I：
10.1016/j.clml.2018.07.145
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-215
引用
收藏
页码：S247 / S247
页数：1
相关论文
共 50 条
  • [21] Thalidomide and dexamethasone as salvage therapy for refractory and relapsed myeloma.
    Palumbo, A
    Giaccone, L
    Bertola, A
    Bringhen, S
    Rus, C
    Triolo, S
    Pileri, A
    Boccadoro, M
    BLOOD, 2000, 96 (11) : 292B - 292B
  • [22] Therapy of relapsed and/or refractory multiple myeloma (RRMM)
    Engelhardt, M.
    Waesch, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 14 - 14
  • [23] Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
    Lonial, Sagar
    Dimopoulos, Meletios
    Palumbo, Antonio
    White, Darrell
    Grosicki, Sebastian
    Spicka, Ivan
    Walter-Croneck, Adam
    Moreau, Philippe
    Mateos, Maria-Victoria
    Magen, Hila
    Belch, Andrew
    Reece, Donna
    Beksac, Meral
    Spencer, Andrew
    Oakervee, Heather
    Orlowski, Robert Z.
    Taniwaki, Masafumi
    Roellig, Christoph
    Einsele, Hermann
    Wu, Ka Lung
    Singhal, Anil
    San-Miguel, Jesus
    Matsumoto, Morio
    Katz, Jessica
    Bleickardt, Eric
    Poulart, Valerie
    Anderson, Kenneth C.
    Richardson, Paul
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (07): : 621 - 631
  • [24] Evolution of Therapy for Relapsed/Refractory Multiple Myeloma
    Castillo, Jorge J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (11): : 1433 - 1436
  • [25] Bendamustine salvage for relapsed - refractory multiple myeloma: a retrospective analysis of outcomes in heavily pretreated patients
    Singh, Aakanksha
    Agrawal, Narendra
    Haldar, Rohan
    Bhurani, Dinesh
    Raychoudhari, Jyoti Shankar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S211 - S211
  • [26] Salvage Therapy with Vorinostat, Lenalidomide, and Dexamethasone (ZRD) in Lenalidomide/Dexamethasone Relapsed/Refractory Multiple Myeloma
    Richter, Joshua R.
    Bilotti, Elizabeth
    McBride, Laura
    Schmidt, Linda
    Gao, Zhijie
    Tufail, Madiha
    Anand, Palka
    McNeill, Ann
    Bednarz, Urszula
    Graef, Thorsten
    Vesole, David H.
    Siegel, David S.
    BLOOD, 2011, 118 (21) : 1706 - 1706
  • [27] Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost
    Bangolo, Ayrton
    Oza, Samir
    Reich-Slotky, Ronit
    Chappell, Aimee
    Siegel, David S.
    Parmar, Harsh
    Biran, Noa
    Vesole, David H.
    Phull, Pooja
    CURRENT STEM CELL RESEARCH & THERAPY, 2025, 20 (02) : 211 - 217
  • [28] Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost
    Bangolo, Ayrton
    Oza, Samir
    Slotky, Ronit
    Chappell, Aimee
    Siegel, David
    Parmar, Harsh
    Biran, Noa
    Vesole, David H.
    Phull, Pooja
    BLOOD, 2022, 140 : 10041 - 10042
  • [29] Strategies for salvage therapy post CAR-T therapy failure in refractory/relapsed multiple myeloma patients
    Min, Chao
    Zhong, Xiong
    Cui, Yue
    Zhang, Hanfu
    Wang, Qingming
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [30] KD-PACE Salvage Therapy for Aggressive Relapsed Refractory Multiple Myeloma, Plasma Cell Leukemia and Extramedullary Myeloma
    Alsouqi, Aseel
    Khan, Muhammad
    Dhakal, Binod
    Du, Liping
    Harrell, Shelton
    Hari, Parameswaran
    Cornell, Robert F.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (08): : 526 - 535
12345